Shyam Srinivasan
Stock Analyst at Goldman Sachs
(0.27)
# 4,506
Out of 4,993 analysts
83
Total ratings
46.2%
Success rate
-11.5%
Average return
Main Sectors:
Stocks Rated by Shyam Srinivasan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NSE: DIVISLAB Divi's Laboratories Limited | Upgraded: Buy | ₹6,375 → ₹8,035 | ₹9,388 | -14.41% | 6 | May 29, 2026 | |
| NSE: DRREDDY Dr. Reddy's Laboratories Limited | Downgraded: Sell | ₹1,200 → ₹1,075 | ₹1,199 | -10.32% | 6 | Apr 23, 2026 | |
| NSE: APOLLOHOSP Apollo Hospitals Enterprise Limited | Reiterated: Buy | ₹7,850 → ₹8,550 | ₹8,959 | -4.57% | 2 | Dec 7, 2025 | |
| NSE: FORTIS Fortis Healthcare Limited | Downgraded: Hold | ₹700.00 → ₹965.00 | ₹905.10 | +6.62% | 2 | Dec 7, 2025 | |
| NSE: KIMS Krishna Institute of Medical Sciences Limited | Initiated Coverage: Buy | ₹900.00 | ₹806.20 | +11.63% | 1 | Dec 7, 2025 | |
| NSE: MAXHEALTH Max Healthcare Institute Limited | Initiated Coverage: Buy | ₹1,325 | ₹1,059 | +25.12% | 1 | Dec 7, 2025 | |
| NSE: ICICIPRULI ICICI Prudential Life Insurance Company Limited | Reiterated: Hold | ₹625.00 → ₹650.00 | ₹497.45 | +30.67% | 3 | Oct 15, 2025 | |
| NSE: LAURUSLABS Laurus Labs Limited | Reiterated: Sell | ₹675.00 → ₹750.00 | ₹1,993 | -62.36% | 8 | Oct 14, 2025 | |
| NSE: NEULANDLAB Neuland Laboratories Limited | Reiterated: Buy | ₹15,750 → ₹17,225 | ₹22,570 | -23.68% | 5 | Oct 14, 2025 | |
| NSE: BIOCON Biocon Limited | Reiterated: Hold | ₹345.00 → ₹335.00 | ₹394.50 | n/a | 6 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹800.00 → ₹775.00 | ₹377.25 | n/a | 5 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹1,300 → ₹1,250 | ₹1,731 | n/a | 3 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | ₹1,375 → ₹1,350 | ₹1,391 | n/a | 5 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | ₹1,435 → ₹1,525 | ₹2,965 | n/a | 5 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ₹1,975 | ₹2,115 | n/a | 4 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹265.00 → ₹250.00 | ₹214.03 | n/a | 3 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹830.00 → ₹890.00 | ₹564.85 | n/a | 2 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ₹465.00 | ₹398.45 | n/a | 1 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹1,860 → ₹2,015 | ₹1,764 | n/a | 3 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | ₹1,650 → ₹1,680 | ₹1,859 | n/a | 2 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | ₹1,325 | ₹1,925 | n/a | 1 | Apr 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | ₹1,475 → ₹1,500 | ₹1,877 | n/a | 4 | Apr 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | ₹1,350 | ₹439.70 | n/a | 1 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | ₹1,675 | ₹598.95 | n/a | 1 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ₹1,975 | ₹1,508 | n/a | 1 | Jan 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.845 | n/a | 1 | Jul 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $12.19 | n/a | 1 | May 2, 2016 |
Divi's Laboratories Limited
May 29, 2026
Upgraded: Buy
Price Target: ₹6,375 → ₹8,035
Current: ₹9,388
Upside: -14.41%
Dr. Reddy's Laboratories Limited
Apr 23, 2026
Downgraded: Sell
Price Target: ₹1,200 → ₹1,075
Current: ₹1,199
Upside: -10.32%
Apollo Hospitals Enterprise Limited
Dec 7, 2025
Reiterated: Buy
Price Target: ₹7,850 → ₹8,550
Current: ₹8,959
Upside: -4.57%
Fortis Healthcare Limited
Dec 7, 2025
Downgraded: Hold
Price Target: ₹700.00 → ₹965.00
Current: ₹905.10
Upside: +6.62%
Krishna Institute of Medical Sciences Limited
Dec 7, 2025
Initiated Coverage: Buy
Price Target: ₹900.00
Current: ₹806.20
Upside: +11.63%
Max Healthcare Institute Limited
Dec 7, 2025
Initiated Coverage: Buy
Price Target: ₹1,325
Current: ₹1,059
Upside: +25.12%
ICICI Prudential Life Insurance Company Limited
Oct 15, 2025
Reiterated: Hold
Price Target: ₹625.00 → ₹650.00
Current: ₹497.45
Upside: +30.67%
Laurus Labs Limited
Oct 14, 2025
Reiterated: Sell
Price Target: ₹675.00 → ₹750.00
Current: ₹1,993
Upside: -62.36%
Neuland Laboratories Limited
Oct 14, 2025
Reiterated: Buy
Price Target: ₹15,750 → ₹17,225
Current: ₹22,570
Upside: -23.68%
Biocon Limited
Aug 8, 2025
Reiterated: Hold
Price Target: ₹345.00 → ₹335.00
Current: ₹394.50
Upside: n/a
Jul 24, 2025
Reiterated: Buy
Price Target: ₹800.00 → ₹775.00
Current: ₹377.25
Upside: n/a
Jul 15, 2025
Reiterated: Buy
Price Target: ₹1,300 → ₹1,250
Current: ₹1,731
Upside: n/a
Jul 15, 2025
Reiterated: Sell
Price Target: ₹1,375 → ₹1,350
Current: ₹1,391
Upside: n/a
Jul 15, 2025
Reiterated: Sell
Price Target: ₹1,435 → ₹1,525
Current: ₹2,965
Upside: n/a
Jul 15, 2025
Reiterated: Hold
Price Target: ₹1,975
Current: ₹2,115
Upside: n/a
Jul 15, 2025
Reiterated: Buy
Price Target: ₹265.00 → ₹250.00
Current: ₹214.03
Upside: n/a
Jul 8, 2025
Reiterated: Buy
Price Target: ₹830.00 → ₹890.00
Current: ₹564.85
Upside: n/a
Jul 8, 2025
Reiterated: Hold
Price Target: ₹465.00
Current: ₹398.45
Upside: n/a
Jul 8, 2025
Reiterated: Buy
Price Target: ₹1,860 → ₹2,015
Current: ₹1,764
Upside: n/a
May 2, 2025
Reiterated: Sell
Price Target: ₹1,650 → ₹1,680
Current: ₹1,859
Upside: n/a
Apr 26, 2025
Reiterated: Sell
Price Target: ₹1,325
Current: ₹1,925
Upside: n/a
Apr 18, 2025
Reiterated: Sell
Price Target: ₹1,475 → ₹1,500
Current: ₹1,877
Upside: n/a
Apr 8, 2025
Initiated Coverage: Buy
Price Target: ₹1,350
Current: ₹439.70
Upside: n/a
Feb 6, 2025
Reiterated: Sell
Price Target: ₹1,675
Current: ₹598.95
Upside: n/a
Jan 19, 2025
Reiterated: Hold
Price Target: ₹1,975
Current: ₹1,508
Upside: n/a
Jul 26, 2021
Reiterated: Hold
Price Target: n/a
Current: $0.845
Upside: n/a
May 2, 2016
Initiated Coverage: Hold
Price Target: n/a
Current: $12.19
Upside: n/a